2015
DOI: 10.1016/j.wneu.2015.02.043
|View full text |Cite
|
Sign up to set email alerts
|

Decision Making for Patients With Concomitant Pituitary Macroadenoma and Ophthalmologic Comorbidity: A Clinical Controversy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
13
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(13 citation statements)
references
References 28 publications
0
13
0
Order By: Relevance
“…Depending on the anatomical position of the optic chiasm (normal position, prefixed or postfixed chiasm), pituitary adenomas with only a 10‐mm to 15‐mm suprasellar growth cause a chiasm defect . Either the tumor compromises the arterial supply of the optic nerve or chiasm or directly compresses the anterior visual pathway itself.…”
Section: Intradural Tumorsmentioning
confidence: 99%
See 1 more Smart Citation
“…Depending on the anatomical position of the optic chiasm (normal position, prefixed or postfixed chiasm), pituitary adenomas with only a 10‐mm to 15‐mm suprasellar growth cause a chiasm defect . Either the tumor compromises the arterial supply of the optic nerve or chiasm or directly compresses the anterior visual pathway itself.…”
Section: Intradural Tumorsmentioning
confidence: 99%
“…Homonymous hemianopia is possible when the unilateral optic tract is compressed. The position of chiasm (normal position, prefixed or postfixed chiasm) has an influence on the pattern of visual field defect . Recently, optical coherence tomography (OCT) has emerged as a quantitative objective method of measuring indirectly the axonal loss of the anterior visual pathway by evaluating the retinal nerve fiber layer thickness .…”
Section: Intradural Tumorsmentioning
confidence: 99%
“…One study was excluded because it was conducted ex vivo on anatomical dissection ( Roebroeck et al, 2008 ). The remaining 39, published between 2007 and 2022, were included in the systematic review ( Akazawa et al, 2010 , Allen et al, 2018 , Altıntaş et al, 2017 , Ather et al, 2019 , Chakravarthi et al, 2021 , Davies-Thompson et al, 2013 , de Blank et al, 2013 , Ge et al, 2015 , Hajiabadi et al, 2015 , Hajiabadi et al, 2016 , He et al, 2021 , Ho et al, 2019 , Hodaie et al, 2010 , Hofer et al, 2010 , Jacquesson et al, 2019a , Jin et al, 2019 , Kamali et al, 2014 , Kammen et al, 2016 , Lacerda et al, 2021 , Lecler et al, 2018 , Liang et al, 2021 , Lin et al, 2018 , Lober et al, 2012 , Ma et al, 2016 , Maleki et al, 2012 , Manners et al, 2022 , Miller et al, 2019 , Puzniak et al, 2019 , Puzniak et al, 2021 , Salmela et al, 2009 , Staempfli et al, 2007 , Takemura et al, 2019 , Tao et al, 2009 , Techavipoo et al, 2009 , Wu et al, 2019 , Yang et al, 2011 , Yoshino et al, 2016 , Zhang et al, 2012b , Zolal et al, 2017 ) .
Fig.
…”
Section: Resultsmentioning
confidence: 99%
“…Eight (20.5%) studies were conducted only on healthy volunteers ( Akazawa et al, 2010 , He et al, 2021 , Hofer et al, 2010 , Jin et al, 2019 , Kamali et al, 2014 , Kammen et al, 2016 , Maleki et al, 2012 , Staempfli et al, 2007 ), seven (17.9%) in patients affected by genetic conditions (e.g., albinism, congenital achiasma, Leber’s hereditary optic neuropathy) ( Ather et al, 2019 , Davies-Thompson et al, 2013 , Lecler et al, 2018 , Manners et al, 2022 , Puzniak et al, 2019 , Puzniak et al, 2021 , Takemura et al, 2019 ), three (7.7%) in patients affected by ophthalmological pathologies (e.g., amblyopia, aniridia, glaucoma) ( Allen et al, 2018 , Altıntaş et al, 2017 , Miller et al, 2019 ), nineteen (48.7%) in patients with tumors or other expansive processes ( de Blank et al, 2013 , Ge et al, 2015 , Hajiabadi et al, 2015 , Hajiabadi et al, 2016 , Ho et al, 2019 , Hodaie et al, 2010 , Jacquesson et al, 2019a , Liang et al, 2021 , Lin et al, 2018 , Lober et al, 2012 , Ma et al, 2016 , Salmela et al, 2009 , Tao et al, 2009 , Wu et al, 2019 , Yoshino et al, 2016 , Zhang et al, 2012b , Zolal et al, 2017 ), one (2.6%) in patients affected by demyelinating disorders (e.g., multiple sclerosis, neuromyelitis optica) ( Techavipoo et al, 2009 ), and two (5.1 %) in patients with other pathologies (traumas, epilepsy) ( Lacerda et al, 2021 , Yang et al, 2011 ) .…”
Section: Resultsmentioning
confidence: 99%
“…Patients with concomitant pituitary adenoma and ophthalmologic comorbidity pose as a clinical dilemma for neurosurgeons and neuro-ophthalmologists. Pre-operative assessment of the retina with OCT and the optic tract via visual pathway diffusion tensor imaging (DTI) tractography are helpful adjuncts for such a multi-disciplinary decision-making [10].…”
mentioning
confidence: 99%